(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(0.30%) $79.24
(1.14%) $1.954
(1.01%) $2 334.30
(1.05%) $27.03
(1.30%) $967.30
(0.04%) $0.933
(0.03%) $11.03
(-0.04%) $0.798
(0.06%) $93.51
0.00% $ 2.65
@ $2.26
Wydano: 12 vas. 2024 @ 16:31
Zwrot: 17.26%
Poprzedni sygnał: vas. 9 - 19:11
Poprzedni sygnał:
Zwrot: -2.59 %
Live Chart Being Loaded With Signals
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States...
Stats | |
---|---|
Dzisiejszy wolumen | 2.12M |
Średni wolumen | 417 575 |
Kapitalizacja rynkowa | 124.99M |
EPS | $-0.362 ( 2024-04-03 ) |
Następna data zysków | ( $-0.360 ) 2024-05-09 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.950 |
ATR14 | $0.00300 (0.11%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-04-03 | Tananbaum James B. | Sell | 520 711 | Common Stock |
2024-04-03 | Tananbaum James B. | Sell | 40 501 | Stock Option (right to buy) |
2024-04-03 | Tananbaum James B. | Sell | 20 250 | Stock Option (right to buy) |
2024-04-03 | Farzan Nima | Sell | 2 186 | Common Stock |
2024-04-03 | Farzan Nima | Sell | 1 281 642 | Stock Option (right to buy) |
INSIDER POWER |
---|
-21.61 |
Last 99 transactions |
Buy: 9 508 542 | Sell: 7 832 534 |
Wolumen Korelacja
Kinnate Biopharma Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Kinnate Biopharma Inc. Korelacja - Waluta/Towar
Kinnate Biopharma Inc. Finanse
Annual | 2023 |
Przychody: | $0 |
Zysk brutto: | $-799 000 (0.00 %) |
EPS: | $-2.42 |
FY | 2023 |
Przychody: | $0 |
Zysk brutto: | $-799 000 (0.00 %) |
EPS: | $-2.42 |
FY | 2022 |
Przychody: | $0 |
Zysk brutto: | $-604 000 (0.00 %) |
EPS: | $-2.59 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-8.31 |
Financial Reports:
No articles found.
Kinnate Biopharma Inc.
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; KIN-3248 small-molecule kinase inhibitors that target cancer-associated alterations in fibroblast growth factor receptors FGFR2 and FGFR3 genes; and small molecule research programs, including Cyclin-Dependent Kinase 12(CDK12) inhibitor in its KIN004 program. The company was incorporated in 2018 and is headquartered in San Francisco, California. Kinnate Biopharma Inc. is a former subsidiary of Fount Therapeutics, LLC.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej